PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 1 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,815 | +15.0% | 3,500 | +67.5% | 0.00% | – |
| Q2 2023 | $9,405 | +12275.0% | 2,090 | -84.3% | 0.00% | -100.0% |
| Q1 2023 | $76 | +261.9% | 13,352 | +278.0% | 0.00% | +100.0% |
| Q4 2022 | $21 | -99.8% | 3,532 | +181.7% | 0.00% | – |
| Q3 2022 | $9,000 | -57.1% | 1,254 | -68.8% | 0.00% | – |
| Q2 2022 | $21,000 | +31.2% | 4,024 | +72.3% | 0.00% | – |
| Q1 2022 | $16,000 | -75.8% | 2,335 | -56.1% | 0.00% | -100.0% |
| Q4 2021 | $66,000 | -39.4% | 5,320 | +52.0% | 0.00% | -66.7% |
| Q3 2021 | $109,000 | +251.6% | 3,499 | +228.5% | 0.00% | +200.0% |
| Q2 2021 | $31,000 | -74.6% | 1,065 | -62.0% | 0.00% | -50.0% |
| Q1 2021 | $122,000 | +713.3% | 2,805 | +1268.3% | 0.00% | – |
| Q4 2020 | $15,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $287,436,000 | 2.91% |
| Baker Brothers Advisors | 10,123,824 | $289,845,000 | 1.27% |
| Logos Global Management LP | 400,000 | $11,452,000 | 0.96% |
| Rock Springs Capital Management LP | 382,359 | $10,947,000 | 0.22% |
| HHLR ADVISORS, LTD. | 583,333 | $16,701,000 | 0.17% |
| Virtus ETF Advisers LLC | 6,622 | $190,000 | 0.08% |
| Jump Financial, LLC | 13,700 | $392,000 | 0.04% |
| ARS Investment Partners, LLC | 7,400 | $212,000 | 0.02% |
| FEDERATED HERMES, INC. | 336,100 | $9,623,000 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 1,287,735 | $36,867,853,000 | 0.02% |